Selective Haematological Cancer Eradication with Shielded HSPCs
Hematopoietic stem cell transplantation is a curative treatment for various hematological malignancies but current methods may lack precision and harm healthy cells.
Join Dr. Romina Matter-Marone, project leader in the Lukas Jeker lab at the University of Basel, as she presents her work on harnessing engineered, shielded hematopoietic stem and progenitor cells to preserve healthy hematopoiesis. She will also discuss developing an antibody-drug conjugate to target the pan-hematopoietic marker CD45 and deplete diseased cells.
Join Dr. Romina Matter-Marone, project leader in the Lukas Jeker lab at the University of Basel, as she presents her work on harnessing engineered, shielded hematopoietic stem and progenitor cells to preserve healthy hematopoiesis. She will also discuss developing an antibody-drug conjugate to target the pan-hematopoietic marker CD45 and deplete diseased cells.
Publish Date:
March 24, 2025
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to º£½ÇÆƽâ°æ Technologies Canada Inc. and its subsidiaries and affiliates (“º£½ÇÆƽâ°æâ€) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.